Navigation Links
Interleukin Genetics Reports First Quarter 2009 Financial Results
Date:5/14/2009

WALTHAM, Mass., May 14 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) today announced financial and operational results for the first quarter ended March 31, 2009.

"In the first quarter we met several of our key corporate objectives. We completed negotiations on a very important research collaboration with a biotech company, presented data from our research related to osteoporosis and obesity at two important scientific conferences, established a European distribution agreement for our Heart Health test product and continued to develop the infrastructure necessary to create our own brand of genetic test products," said Lewis H. Bender, Chief Executive Officer. "Looking ahead to the rest of the year, we are preparing to launch our own genetic test brand, and continue to hold discussions with companies regarding partnering opportunities for our various programs, products, intellectual property and genetic biomarker expertise."

Revenue for the three months ended March 31, 2009, was $1.9 million compared to $2.7 million for the same period in the prior year. The decrease was primarily attributable to the effect current economic conditions have had on consumer product revenue. Genetic test revenue increased this quarter over the same period in the prior year as we experience positive growth in that segment of our business.

Research and development expenses were $0.9 million for the three months ended March 31, 2009 compared to $0.8 million for the same period in the prior year. The increase is primarily attributable to ongoing costs associated with our patent portfolio. In addition, we continue to allocate resources to projects underway with Alticor as well as the development of our own genetic test products.

Selling, general and administrative expenses were $2.0 mill
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
2. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
3. Interleukin Genetics Announces Conference Call to Discuss First Quarter 2009 Results
4. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
5. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
6. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
7. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
8. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
9. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
10. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... study has found that India,s shocking rates of suicide ... who are clinging to tiny smallholdings less than ... such as cotton and coffee, that are highly susceptible ... range of previous case studies that point to a ... the ,liberalisation, of the nation,s economy during the 90s. ...
(Date:4/17/2014)... patients adrenaline after they suffer a cardiac arrest outside ... surviving long-term, according to new research conducted at St. ... have a cardiac arrest get adrenaline, which has been ... said Dr. Steve Lin, an emergency physician and trauma ... medical treatment, long-term survival rates of patients who suffer ...
(Date:4/17/2014)... as the leading weapon against the deadly disease could ... research indicating it simply needs to be administered differently. ... cheap anti-malarial drug chloroquine in treating and preventing the ... half a million people each year around the world. ... to chloroquine, but research carried out at the Australian ...
(Date:4/16/2014)... Consider the marvel of the embryo. It begins as ... as they multiply to become the cells of our lungs, ... body. , Now, in a feat of reverse tissue engineering, ... coding that allows embryonic cells to proliferate and transform into ...
(Date:4/16/2014)... Therapeutics, Inc. (NASDAQ: CLDX) announced today that final data ... tumors, including long-term patient follow-up, have been published in ... The data demonstrate robust antibody and T cell responses ... advanced cancers and suggest that CDX-1401 may predispose patients ...
Breaking Medicine News(10 mins):Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Scientists find new way to fight malaria drug resistance 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4
... French and Spanish . , Researchers at ... ,gene E, which leads to the death of tumour cells derived from ... this new gene is that its use to fight cancer can reduce ... effective treatment for cancer. This research was conducted by Ana ...
... ... Surgeons (ASPS), are available to discuss the recently proposed cosmetic surgery tax. , ... Arlington Heights, IL (Vocus) ... Surgeons (ASPS), are available to discuss the recently proposed cosmetic surgery tax., , ,WHAT: ...
... ... IVD manufacturers, distributors and industry service providers about the state of their company, international ... ... medical device regulatory consulting firm Emergo Group Inc. recently surveyed medical device and ...
... ... in a national movement to raise awareness for a disease that affects 24 million Americans. ... Richmond, VA (Vocus) November ... recognizes National Diabetes Awareness Month, observed annually during the month of November. Nearly 24 ...
... ... report on how to generate free leads through your website. , ... (PRWEB) November 24, 2009 -- 2009 has been another ... the strain to keep their businesses afloat and reduce costs. Typically the first items on ...
... , RESTON, Va., Nov. 24 Lincoln County ... Maine with two small hospitals and retirement communities, employing more than 1,200 ... you,re not getting successful backup, you,re not doing your job," says Brooks ... case with many hospitals in Maine, budgets are extremely tight for LCH, ...
Cached Medicine News:Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:Leading Plastic Surgery Experts Available to Discuss Proposed ,Cosmetic Surgery Tax 2Health News:Medical Device Industry Positive About 2010 – Survey 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 3Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems 2
(Date:1/14/2014)... Jan. 14, 2014  Luminex Corporation (Nasdaq: LMNX ) ... fourth quarter of 2013 on Monday, February 3, 2014. A ... the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ... discuss the operating highlights and financial results for the fourth ...
(Date:1/14/2014)... Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s ... a targeting guide with accompanying instrumentation to place and ... adjunct to the soft tissue (e.g. ligament) repair or ... tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... The Advanced Wound Management Division of Smith & Nephew, ... SN; NYSE: SNN ), highlighted the results of ... Wound Therapy (NPWT) achieves many of the common treatment ... a reduction in wound dimension, exudate, and improvement in ...
... Medical Holdings Corporation ("Select") (NYSE: SEM ), the ... had received notice of the exercise of the underwriters, ... Select,s common stock at a price per share of ... 2009, subject to customary closing conditions. The over-allotment option ...
Cached Medicine Technology:Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT 2Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT 3Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT 4Select Medical Holdings Corporation Announces Exercise of Underwriters' Option to Purchase Additional Shares 2
HST, multi frequency Side Fire "T intraoperative transducer. A wide field of view is this transducers benefit....
This convex sector mechanical sector transducer provides real-time photo-realistic images....
Wide band, Super High Density endovaginal transducer provides a 180 field of view allowing imaging of the entire uterus and cervix with minimal transducer movement....
Provides tremendous image quality along with a 180 degree field of view....
Medicine Products: